DAVID GRANOVSKY

Posts Tagged ‘stock’

OPRAH, MICHAEL J FOX, DR OZ – STEM CELL DEBATE IS DEAD!

In VICTORIES & SUCCESS STORIES on October 22, 2011 at 9:15 am

The debate ended 2.5 years ago but the battle still wages on! SO much has changed in 2.5 years  yet so much remains the same. 

The world has embraced the knowledge that adult stem cells can treat almost anything with safety and success but nobody in the USA knows about it because they are not available here and considered “unapproved by the FDA.”

Maybe we can enlist the “Occupy Wall Street” peeps to make some huge needed changes in our health care and available treatments.  – David

Originally from: https://repairstemcell.wordpress.com/2009/03/31/oprah-michael-j-fox-dr-mehmet-oz-the-stem-cell-debate-is-over/

The Stem Cell Debate Is Over! ...sort of...

The Wisdom of Oz

Visualize the surreal image of Oprah Winfrey, Michael J Fox and Dr. Mehmet Oz, wearing purple surgical gloves, sitting on stage around a human brain. Dr. Oz explains the absence of Nigro-Striatal Neurons in the brain of Parkinson’s patients while lifting out partially dissected chunks of brain and placing them into Michael’s shaking hand.

The camera zooms in as Dr. Oz steadies Michael’s hand in his. Dr. Oz weaves an intimidating, steel needle between Michael’s gloved and trembling fingers and illustrates the procedure for injecting stem cells into the brain by plunging it both into and through the quivering cerebellum. Michael’s legs spasm and contort and my stomach clenches empathetically with what I sense is Michael’s extreme discomfort, but is really a symptom of his condition.

And yet, NOTHING could have prepared me for what happened next as Dr. Oz, unbelievably and without prelude or warning, makes the stunning statement:
“I think, Oprah, the stem cell debate is dead.”

“The problem with embryonic stem cells is that embryonic stem cells come from embryos, like all of us are made from embryos, and those cells can become any cell in the body, but it’s very hard to control them and so they can become cancer.”

While astonished by his public announcement, I soon began to wonder: “why did Dr Oz only briefly allude to the potential of iPS cells and the proven benefits of adult stem cell treatments?” And then it became clear.

Dr Oz recognizes that the average person on an American street is led to believe, “a stem cell is an embryo is a stem cell”. Due to years of misleading media saturation, as far most Americans know, there are no other stem cells besides embryonic. Walk down the street and ask someone “what is an adult stem cell…what is an iPS cell”, and your inquiries will surely be met by blank stares.

So in retrospect, what Oz DID do, was truly…amazing.

Shunning the history of the love/hate affair Americans have with Embryonic stem cell research and ignoring the majority of US media over the past 5 years, the decrees of President Obama’s funding policies, the positions of the FDA and AMA and the fruitless decade long public pursuit of embryonic cures undertaken by Michael J Fox (with the benevolent and optimistic spirit of Christopher Reeve hovering over him) and before the bewildered eyes of Michael, Oprah and ~7.2 million viewers, Dr Mehmet Oz nailed the coffin shut on ESC treatments:
“I think, Oprah, the stem cell debate is dead.”

With this one simple statement on national TV, Dr Oz has taken the first step towards educating the American public about the current insurmountable limitations of embryonic stem cells and cracked open the door to the American collective mind-set regarding the potential of iPS cells and the reality that Repair stem cells (RSC) have been treating diseases around the world successfully for a decade. Despite the fact that thousands of American doctors refer to RSC as “snake oil,” more and more American patients are realizing that the US medical system is faltering, dated and just not working while the greatest medicine the world has ever seen is available just beyond the borders of their own country.

The seeds planted by Dr Oz will take a long time to find purchase in the collective American mind-set. There is too much embryonic momentum, media and drama, and America loves drama. Embryonic stem cells will not go away and like Romeo and Juliet, this love/hate affair may have to run its course for most, despite Dr Oz stealing the “distilled liquor” and Romeo’s poison and dagger in an attempt to avoid all of the deaths at the end of this play.

To read more about this grim fairy tale: https://repairstemcell.wordpress.com/2009/03/30/a-grim-fairy-tale-americas-doomed-love-affair-with-embryonic-stem-cell-research-intro-the-romance-is-an-illusion/

One step at a time we will climb this mountain and slowly open American eyes to improve their knowledge of treatment options so all can intelligently exercise the freedom of choice in their individual medical care. One inch at a time, Oz wisely created a pathway to an amazing new world of available medical treatments for what were previously believed to be incurable diseases and are in fact treating patients successfully around the world.

Dr Oz took this first step and it was a HUGE first step!

So from where I am sitting, I would like to express my heartfelt and sincerest appreciation for Dr Oz’s bravery, statements and actions. Thank you, Dr. Oz and thank you Oprah; for allowing this sage doctor the forum to break the walls restricting millions of Americans from the knowledge of the medical treatment options they so unquestionably deserve.

Here is the actual transcript based on my ears and fingers and a lot of patient rewinding:

“I think, Oprah, the stem cell debate is dead.”

“The problem with embryonic stem cells is that embryonic stem cells come from embryos, like all of us are made from embryos, and those cells can become any cell in the body, but it’s very hard to control them and so they can become cancer.”

“I can take a little bit of your skin, take those cells, get them to go back in time so they are like they were when you were first made, and then they will start to make that dopamine & I think those cells, because they won’t be as prone to cancer & because they’re your genes will be the ones that are ultimately used to cure Parkinsons.”

“I think we are single digit years away from making a big impact in the lives of Parkinson’s disease but also diabetics, heart disease, people who have had a lot of problems.”

To see the original video: http://www.oprah.com/media/20090319-tows-dr-oz-brain

Advertisements

OVER HALF OF HEART EXPERTS HAVE CONFLICTS OF INTEREST

In OFF THE BEATEN PATH on March 29, 2011 at 12:53 pm

(Reuters) – Half of the experts involved in writing recent treatment guidelines for heart patients reported a conflict of interest, U.S. researchers said on Monday, raising worries about whose interests are being served.

https://i0.wp.com/www.naturalnews.com/cartoons/conflict_of_interest_600.jpg

Even though the experts are disclosing their ties to companies that produce heart drugs and devices, the phenomenon is important because the guidelines they produce are used to help train new doctors, thus can have long-lasting impact on the way patients are treated…

Of the nearly 500 people studied, 56 percent reported a conflict of interest. The most common conflicts included being a consultant or serving on a company advisory board, followed by getting a research grant, taking money for serving on a speakers’ bureau and owning stock…

Study looks at ties between firms, heart experts | Reuters.

AUTISM/ASPERGER’S + STEM CELLS

In VICTORIES & SUCCESS STORIES on February 10, 2011 at 9:41 am

A friend asked:

when are they going to allow us to use stem cells for autism in this country??? I am getting impatient every treatment center I’ve called here (in the US) says they wont do it! I am having a baby in feb and want to use the cord blood for my son but when will I ever be able to? anyone know?

WHY NO STEM CELLS IN THE US (FOR AUTISM)? – https://repairstemcell.wordpress.com/why-no-stem-cells-in-the-us/

STEM CELLS FOR AUTISM – PROGRESS TO DATE – https://repairstemcell.wordpress.com/2009/10/26/stem-cells-for-autism/

POTENTIAL OF STEM CELL TREATMENTS FOR AUTISM – https://repairstemcell.wordpress.com/2009/10/16/potential-of-stem-cell-treatments-for-autism/

TREATMENTS AVAILABLE TODAY – Asperger’s is an Autism Spectrum Disorder.  To see if you or your loved one might be a candidate for Stem Cell Therapy, contact me at dsgrano@gmail.com

CDC VACCINE COVER UP – MERCURY ACTUALLY DOES CAUSE AUTISM? Central Figure in CDC Vaccine Cover-Up Absconds With $2M

THE COST OF NOT PURSUING ADULT STEM CELL TREATMENTS IN THE USA

In VICTORIES & SUCCESS STORIES on February 9, 2011 at 9:40 am
COST BY DISEASE # OF PATIENTS COST PER YEAR
TYPE 1 DIABETES 5.8 MILLION PATIENTS $125.1 BILLION
STROKE 5.7 MILLION PATIENTS $62.7 BILLION
HEART FAILURE 5.2 MILLION PATIENTS $50.7 BILLION
SPINAL CORD INJURY 250,000 PATIENTS $37.2 BILLION
PARKINSON’S DISEASE 650,000 PATIENTS $23 BILLION

TOTAL COST THAT ADULT STEM CELLS COULD SAVE THE UNITED STATES

$250 BILLION PER YEAR


Cord Blood America Says Two Recent Financial Transactions Strengthen Company’s Balance Sheet

In BUSINESS OF STEM CELLS on August 6, 2010 at 12:55 pm

(OTCBB: CBAI – Cord Blood America, Inc.)

https://i0.wp.com/media.marketwire.com/attachments/200901/433220_MWUpload_CBAILogo.jpg

LATEST NEWS!! Cord Blood America Says Two Recent Financial Transactions Strengthen Company’s Balance Sheet

LAS VEGAS, Aug 05, 2010 — Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today said that it has had positive movement on two financial obligations that further strengthen its balance sheet.

The Company announced it has retired a $1.1 million debt obligation with JMJ Financial. “Eliminating debt and getting to cash flow positive are paramount to the long term success of CBAI,” said Matthew Schissler, co-founder and CEO. “We are laser focused on these two goals.” Also, in a Form 8-K filing, Cord Blood America announced, after extensive negotiations, it has canceled a 36 million share Warrant Agreement valued at $1.8 million with Shelter Island Opportunity Fund, LLP, and replaced it with a Senior Secured Note in the principal amount of $1,590,400.

“This obligation was under the derivative liability line on our balance sheet, and as a result, now gets paid down over the next 12 months, making our balance sheet stronger. We took 36 million warrants off the table. The obligation in total was reduced by over $300,000 by our calculations. Interest is only for 6 months and payable in cash. We believe reducing the principal and interest obligation, removing warrant overhang, reducing the derivative liability over the next 12 months are all good for shareholders,” said Matthew Schissler, co-founder and CEO. “It is important that our shareholders understand that we are continually working to improve our financial condition, as well as acquiring new businesses and diversifying our revenue stream.” About Cord Blood America Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/.

via www.StockMarketingInc.com: Stock Marketing Inc Presents!! ERFW,ADLS,ELRA,CBAI,VKNG,WSRA:: Sign Up With Us Today!! | TradingMarkets.com.

International Stem Cell Corporation Signs Financing Agreement – Yahoo! Finance

In BUSINESS OF STEM CELLS on May 6, 2010 at 1:02 pm

International Stem Cell Corporation Signs Financing Agreement

Press Release Source: International Stem Cell Corporation On Wednesday May 5, 2010, 7:30 am EDT

OCEANSIDE, Calif.–BUSINESS WIRE–International Stem Cell Corporation OTCBB:ISCO, http://www.intlstemcell.com, today announced it has entered into a definitive agreement dated May 4, 2010 ‘the Agreement” with Socius CG II, Ltd. “Socius”, pursuant to which Socius has committed to purchase a single tranche of up to $10 million in non-convertible Series F Preferred Stock the “Preferred Stock” from ISCO.

The Company issued a warrant to purchase $13,500,000 worth of the Company’s Common Stock, the exercise price of the warrant being determined by the closing bid price for the Company’s Common Stock on the trading day immediately preceding the date the Company initiates the sale of the Series F Preferred…

via International Stem Cell Corporation Signs Financing Agreement – Yahoo! Finance.

THE EMBRYONIC STEM CELL HOAX: A HISTORY OF THE GERON SCANDAL

In ALL ARTICLES on February 20, 2010 at 11:43 pm

02/20/2010

THE EMBRYONIC STEM CELL HOAX: – A HISTORY OF THE GERON SCANDAL


For six years, the American people’s understanding of stem cells has been overwhelmed by rampant misinformation and deception. We were led to believe the future of medicine lies in Embryonic Stem Cells (ESC) and that Repair (adult) Stem Cells (RSC) are “snake oil.”
These skewed stories of ESC hope and RSC failure intentionally misled the American people in general and forced spinal cord patients to pay for the false-hope of ESC treatments in order to line the pockets of the  ESC promoters.

 

PFIZER BUYS INTO ADULT/REPAIR STEM CELL COMPANY ATHERSYS

In BUSINESS OF STEM CELLS, VICTORIES & SUCCESS STORIES on December 21, 2009 at 1:18 pm

PFIZER BUYS STEM CELL COMPANY ATHERSYS & Acquires Stem-Cell Therapy Product MulitStem

By ANDREW POLLACK

Published: December 21, 2009 – Pfizer said Sunday that it was buying the rights to a somewhat controversial cell therapy from Athersys, a biotechnology company — a sign of big pharmaceutical companies’ growing interest in (ADULT or REPAIR)  stem cells.

Why is this controversial? There are no embryos involved.  These are adult or repair stem cells.  There are thousands of clinical trials and tens of thousands of scholarly papers showing their safety and efficacy.  If a new cancer drug comes out that is not through all stages of clinical trials it is not controversial; why is this? -dg

Athersys’s cells, derived from human bone marrow (these are Adult or Repair Stem Cells, not embryonic – dg), have not yet been tested in people with inflammatory bowel disease, a term that encompasses ulcerative colitis and Crohn’s disease. But the product, called MultiStem, is in early human testing as a treatment for heart attacks and for cancer patients receiving bone marrow transplants.

Pfizer will have the rights to develop Athersys’s cells to treat inflammatory bowel diseases, the companies are expected to announce on Monday.

Irritable Bowel Syndrome + Crohn's Disease Treatment Info

CLICK PICTURE for Irritable Bowel Syndrome, Colitis, Crohn's Disease Treatment Info

STOCK ALERT

Pfizer will pay Athersys $6 million initially and up to $105 million in the future.  Athersys [ NASDAQ:ATHX ] soared as high as $3.95 today on the news and has leveled off to $2.80, a 180% gain by noon today.)

via Pfizer Acquires MultiStem, a Therapy Based on Stem Cells – NYTimes.com.

For more info:

BRAINSTORM (ISRAEL) STEM CELL THERAPY TREATMENT READY FOR CLINICAL TRIALS

In BUSINESS OF STEM CELLS on November 15, 2009 at 11:30 pm

http://vancityguy.files.wordpress.com/2008/12/brainstorm.jpg

BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that its chief medical advisor, Professor Eldad Melamed, was interviewed on November 9, 2009 on Israel?s most popular radio broadcast, Galei Zahal. The interview was conducted by Yaron Willensky, a respected news talk show host, to discuss the latest achievements, treatment and progress of BrainStorm?s stem cell technology and therapy with respect to neurodegenerative diseases such as ALS and Parkinson?s disease.

?The stem cell therapy treatment is ready. We have successfully been able to process autologous adult human mesenchymal stem cells, grow them and differentiate them into other cell types for the treatment of neurodegenerative diseases. We are currently in middle of obtaining approval to begin the first clinical trials on ALS patients in Israel,? stated Professor Melamed during the interview. ?Regarding clinical trials for Parkinson?s disease, we are ready to begin,? continued Professor Melamed. ?However, we must still complete the regulatory approval process before that can happen.?

via PROFESSOR – BRAINSTORM CHIEF MEDICAL ADVISOR INTERVIEWED ON ISRAEL RADIO BROADCAST; STATES STEM CELL THERAPY TREATMENT READY FOR CLINICAL TRIALS :: UNTERNEHMENSNACHRICHTEN.

Geron’s Stem Cell Trial

In BUSINESS OF STEM CELLS on November 3, 2009 at 11:07 am

[For more articles on the long, sordid and somewhat pathetic history of Geron’s embryonic stem cell clinical trial to treat spinal cord injury, click here]

Spinal Cord Injury

Geron Corporation’s Stem Cell Trial

Monday November 2, 2009

Geron Corporation is a company based in Menlo Park, CA and the first biotech company in the USA to be granted permission for a clinical trial of regenerative medicine using embryonic stem cells, in humans. While permission was granted in January 2009, the trials were put on hold until last Friday (October 30, 2009) when the latest round of preclinical trials using animals revealed some side effects that warranted further investigation.

According to the Geron News Release, test animals receiving the treatment, GRNOPC1, developed a higher number of cysts at the area of spinal cord injury than in previous studies. However, the FDA has agreed to allow the studies to continue, since the cysts appear to be non-proliferative, confined to the injury site, and not associated with any serious adverse effects or SUSARS.

GRNOPC1 consists of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells (OPCs). Oligodendrocytes are cells of the nervous system that produce the myelin shealth, which insultates the axons of nerve cells. Injection with the cells was shown to enhance remyelination of the spinal cord in adult rats. Demyelination after spinal cord injury contributes to loss of neural function. Rats treated with GRNOPC1 seven days after injury exhibited substantially better recovery and improved locomotor ability.

Geron expects re-initiation of the clinical trial in late 2010. Since the treatment must be applied shortly after injury, anyone wanting to participate in a clinical trial must agree to injections within 7 to 14 days of spinal injury…

via Geron Corporation’s Stem Cell Trial.

%d bloggers like this: